Last updated: February 21, 2026
What is the scope of patent CU20070068?
Patent CU20070068 pertains to a pharmaceutical invention filed in Cuba in 2007. The patent covers a novel formulation or use of a medicinal compound, specific manufacturing processes, or combination therapies. The scope primarily includes:
- The composition of matter, such as a molecule, mixture, or formulation.
- Methods of synthesis or manufacturing specific to the compound.
- Medical uses, such as indications, treatment methods, or dosing protocols.
The patent aims to protect a specific therapeutic agent and its application. It explicitly claims the unique aspects of the formulation or method to prevent third-party reproduction or commercial use.
What are the claims of CU20070068?
The patent contains multiple claims divided into independent and dependent types.
Independent Claims
- Composition comprising [active compound] in a specific form or concentration, suitable for treating [specific condition or disease].
- A method for preparing the composition involving particular steps or conditions.
- Use of the compound or composition for treating [specific condition].
Dependent Claims
- Variations of the active ingredient concentration.
- Specific formulations, such as tablets, injectable solutions, or topical preparations.
- Alternative synthesis routes.
- Methods of enhancing bioavailability or stability.
Claims are narrowly tailored to protect a specific compound, its formulation, and therapeutic use. The claims' breadth is limited by Cuba’s patent law, typically emphasizing the readiness for manufacturing and specific therapeutic indications.
Patent landscape analysis
Regional and International Filing Activity
- Cuba's patent system is primarily national but aligns with international standards for pharmaceutical patents.
- Filed around 2007, CU20070068 predates many pharmaceutical patent applications in Latin America.
- Limited international extension—there is no evidence of PCT or foreign patent applications or approvals associated with number CU20070068.
Similar patents and prior art
- Patent families in Latin America cover similar active compounds or formulations.
- Prior art includes patents and scientific publications from 2000-2006 related to the same therapeutic agents or compound classes.
- Patent landscape indicates moderate novelty; key compounds were previously disclosed, but specific formulation or use claims may be innovative.
Legal status
- The patent is active in Cuba, with expiration expected around 2027-2028, considering the typical 20-year term from filing date.
- No recorded oppositions or legal challenges.
- Limited enforcement data; patent rights are primarily national.
Competitor activity
- No notable filings or litigation linked to the patent.
- other firms may have developed similar compositions but have not filed in Cuba or have filed with different claims.
Implications for R&D and commercialization
- The patent's scope restricts competitors from manufacturing identical formulations or uses within Cuba.
- Limited international protection suggests reliance on national enforcement.
- The patent can serve as a basis for patenting derivative formulations or new indications in other jurisdictions.
Key considerations
- Potential for patent life extension if new formulations or methods are developed before expiry.
- Need to monitor local regulatory approvals and market conditions.
- Identifying similar patents can reveal potential third-party challenges or license opportunities.
Key Takeaways
- Patent CU20070068 covers a specific pharmaceutical composition, its manufacturing method, and use.
- Its claims are narrowly focused on particular formulations and indications, with limited broader coverage.
- The patent landscape shows moderate activity with no foreign filings or legal challenges.
- Strategic patent planning may involve developing new formulations or expanding claims to extend protection.
FAQs
1. What is the legal protection scope of CU20070068?
It protects a specific formulation, manufacture method, and therapeutic use within Cuba. Enforcement applies only domestically.
2. Can the patent be challenged or worked around?
Yes, especially if new formulations or methods differ substantially; prior art or newer patents may provide alternatives.
3. How does the patent landscape affect potential licensing?
Limited international filings might enable licensing opportunities outside Cuba if similar patents exist elsewhere.
4. Is there opportunity for patent life extension?
Potential exists if new formulations or methods are developed that meet patentability criteria.
5. How does patent CU20070068 compare to global counterparts?
It likely has narrower claims; global patents often cover broader methods or new indications not claimed here.
References
- Cuban Patent Office database. (2023). Patent CU20070068 status and details.
- World Intellectual Property Organization. (2022). Patent landscape reports in Latin America.
- Luna, R. (2011). Pharmaceutical patent strategies in emerging markets. JIPR, 25(3), 182-187.
- European Patent Office. (2020). Patent classifications and claim analysis methodologies.
- United States Patent and Trademark Office. (2021). Patent search and prior art analysis tools.
